tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RYTM Stock Latest News

Rhythm Pharmaceuticals: Buy Rating Backed by FDA Priority Review and Positive Phase 3 Results
RatingsRhythm Pharmaceuticals: Buy Rating Backed by FDA Priority Review and Positive Phase 3 Results
16d ago
RYTM
Rhythm Pharmaceuticals announces FDA acceptance of sNDA for setmelanotide
PremiumThe Fly
Rhythm Pharmaceuticals announces FDA acceptance of sNDA for setmelanotide
17d ago
RYTM
Rhythm Pharmaceuticals Advances Genetic Obesity Treatment with Setmelanotide Study
PremiumCompany Announcements
Rhythm Pharmaceuticals Advances Genetic Obesity Treatment with Setmelanotide Study
22d ago
RYTM
Rhythm Pharmaceuticals’ RM-718 Study: A Potential Game-Changer in Obesity Treatment
PremiumCompany Announcements
Rhythm Pharmaceuticals’ RM-718 Study: A Potential Game-Changer in Obesity Treatment
22d ago
RYTM
Rhythm Pharmaceuticals Advances Genetic Obesity Treatment with Setmelanotide Study
PremiumCompany Announcements
Rhythm Pharmaceuticals Advances Genetic Obesity Treatment with Setmelanotide Study
24d ago
RYTM
Rhythm Pharmaceuticals’ RM-718 Study: A Potential Game-Changer in Obesity Treatment
PremiumCompany AnnouncementsRhythm Pharmaceuticals’ RM-718 Study: A Potential Game-Changer in Obesity Treatment
24d ago
RYTM
3 Best Stocks to Buy Now, 8/8/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 8/8/2025, According to Top Analysts
29d ago
CI
WIX
Strong Q2 Performance and Strategic Investments Drive Buy Rating for Rhythm Pharmaceuticals
Premium
Ratings
Strong Q2 Performance and Strategic Investments Drive Buy Rating for Rhythm Pharmaceuticals
1M ago
RYTM
Rhythm Pharmaceuticals price target raised to $100 from $80 at H.C. Wainwright
PremiumThe Fly
Rhythm Pharmaceuticals price target raised to $100 from $80 at H.C. Wainwright
1M ago
RYTM
Rhythm Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
PremiumCompany Announcements
Rhythm Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
1M ago
RYTM
Positive Outlook on Rhythm Pharmaceuticals: Strong Growth Potential and Strategic Advancements Support Buy Rating
PremiumRatings
Positive Outlook on Rhythm Pharmaceuticals: Strong Growth Potential and Strategic Advancements Support Buy Rating
1M ago
RYTM
Optimistic Buy Rating for Rhythm Pharmaceuticals Driven by Strong Sales and Promising Growth Prospects
PremiumRatings
Optimistic Buy Rating for Rhythm Pharmaceuticals Driven by Strong Sales and Promising Growth Prospects
1M ago
RYTM
Rhythm Pharmaceuticals price target raised to $135 from $130 at Citizens JMP
PremiumThe FlyRhythm Pharmaceuticals price target raised to $135 from $130 at Citizens JMP
1M ago
RYTM
Rhythm Pharmaceuticals Reports Strong Q2 2025 Growth
Premium
Company Announcements
Rhythm Pharmaceuticals Reports Strong Q2 2025 Growth
1M ago
RYTM
Rhythm Pharmaceuticals price target raised to $109 from $100 at Morgan Stanley
Premium
The Fly
Rhythm Pharmaceuticals price target raised to $109 from $100 at Morgan Stanley
1M ago
RYTM
Positive Outlook for Rhythm Pharmaceuticals: Strong Revenue Performance and Promising Future Catalysts Justify Buy Rating
PremiumRatings
Positive Outlook for Rhythm Pharmaceuticals: Strong Revenue Performance and Promising Future Catalysts Justify Buy Rating
1M ago
RYTM
Rhythm Pharmaceuticals reports Q2 EPS (75c), consensus (67c)
PremiumThe Fly
Rhythm Pharmaceuticals reports Q2 EPS (75c), consensus (67c)
1M ago
RYTM
Rhythm Pharmaceuticals announces anticipated upcoming milestones
PremiumThe Fly
Rhythm Pharmaceuticals announces anticipated upcoming milestones
1M ago
RYTM
Rhythm Pharmaceuticals enrolls first patient in Part C of Phase 1 RM-718 trial
PremiumThe Fly
Rhythm Pharmaceuticals enrolls first patient in Part C of Phase 1 RM-718 trial
1M ago
RYTM
Rhythm Pharmaceuticals sees FY25 non-GAAP operating expense $285M-$315M
PremiumThe FlyRhythm Pharmaceuticals sees FY25 non-GAAP operating expense $285M-$315M
1M ago
RYTM
Rhythm Pharmaceuticals sees cash sufficient to fund operations for 24 months
Premium
The Fly
Rhythm Pharmaceuticals sees cash sufficient to fund operations for 24 months
1M ago
RYTM
Strong Future Performance and Market Adoption Drive Buy Rating for Rhythm Pharmaceuticals
Premium
Ratings
Strong Future Performance and Market Adoption Drive Buy Rating for Rhythm Pharmaceuticals
1M ago
RYTM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >